AMPHISTA THERAPEUTICS LIMITED
PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)This company is commonly known as Amphista Therapeutics Limited. The company was founded 7 years ago and was given the registration number 11119959. The firm's registered office is in LONDON. You can find them at 158-160 North Gower Street, , London, . This company's SIC code is 72110 - Research and experimental development on biotechnology.
Company Information
| Name | : | AMPHISTA THERAPEUTICS LIMITED |
|---|
| Company Number | : | 11119959 |
|---|
| Company Type | : | PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital) |
|---|
| Status | : | Active |
|---|
| Incorporation Date | : | 20 December 2017 |
|---|
| Industry Codes | : | - 72110 - Research and experimental development on biotechnology
|
|---|
Office Address & Contact
| Registered Address | : | 158-160 North Gower Street, London, England, NW1 2ND |
|---|
| Country Origin | : | ENGLAND |
|---|
| Telephone | : | Unreported |
|---|
| Email Address | : | Unreported |
|---|
| Website | : | Unreported |
|---|
| Social | : | Unreported |
|---|
People with Significant Control
| Advent Life Sciences Llp |
| Notified on | : | 28 June 2019 |
|---|
| Status | : | Active |
|---|
| Country of residence | : | United Kingdom |
|---|
| Address | : | 27, Fitzroy Square, London, United Kingdom, W1T 6ES |
|---|
| Nature of control | : | - Ownership of shares 25 to 50 percent
- Voting rights 25 to 50 percent
|
|---|
| Advent Life Sciences Fund Ii Lp |
| Notified on | : | 28 June 2019 |
|---|
| Status | : | Active |
|---|
| Country of residence | : | England |
|---|
| Address | : | 158-160, North Gower Street, London, England, NW1 2ND |
|---|
| Nature of control | : | - Significant influence or control
|
|---|
| Dr Alessio Ciulli |
| Notified on | : | 27 February 2018 |
|---|
| Status | : | Active |
|---|
| Date of birth | : | July 1977 |
|---|
| Nationality | : | Italian |
|---|
| Country of residence | : | England |
|---|
| Address | : | 158-160, North Gower Street, London, England, NW1 2ND |
|---|
| Nature of control | : | - Ownership of shares 25 to 50 percent
|
|---|
| Advent Life Sciences Llp |
| Notified on | : | 20 December 2017 |
|---|
| Status | : | Active |
|---|
| Country of residence | : | England |
|---|
| Address | : | 158-160, North Gower Street, London, England, NW1 2ND |
|---|
| Nature of control | : | - Ownership of shares 25 to 50 percent
|
|---|
| Advent Life Sciences Fund Ii Lp |
| Notified on | : | 20 December 2017 |
|---|
| Status | : | Active |
|---|
| Country of residence | : | England |
|---|
| Address | : | 158-160, North Gower Street, London, England, NW1 2ND |
|---|
| Nature of control | : | - Ownership of shares 25 to 50 percent
- Voting rights 25 to 50 percent
|
|---|
Account Documents
Accounts
- Last accounts submitted for period 31 March 2023 (1 year ago)
- Accounts type was MICRO
- Next accounts dated 31 March 2024
- Due by 31 December 2024 (1 months remaining)
Confirmation Statement
- Last submitted on 14 October 2023 (1 year ago)
- Next confirmation dated 14 October 2024
- Due by 28 October 2024 (3 months remaining)